Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Retatrutide (20 mg (lyophilized)) Research Use Only (RUO) Canada About this compound Retatrutide is a triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously
Study after study proves the efficacy of GLP-1s across countless indications with some concern around long-term side effects and weight regain
From the logistic regression model for responder analysis, semaglutide- vs placebo-treated patients had a significantly lower odds of 5-points deterioration: 0.49 (95% CI: 0.35-0.68
As the body adjusts, the doses increases, continuing until the goal weight is reached
The company also wins high marks for its commitment to sourcing ingredients for its meals from small, local, organic farms while ensuring all proteins are produced using free-range, humane methods and seafood is responsibly wild-caught
